Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TELEFLEX INCORPORATED

(TFX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Teleflex Unveils the UroLift Advanced Tissue Control System and the UroLift 2 System

09/09/2021 | 06:30am EDT

Teleflex Incorporated announced that two new UroLift System products, the UroLift Advanced Tissue Control (ATC) System and the UroLift 2 System, will be launched at the American Urological Association (AUA) 2021 Annual Meeting taking place virtually September 10–13. New emerging data from the largest analysis of U.S. healthcare claims within the field of benign prostatic hyperplasia (BPH) comparing complication rates (defined as a post-operative procedure performed during a return visit to an outpatient setting) and surgical retreatment rates of BPH procedures, including the UroLift System, will also be presented. The UroLift ATC System builds on the highly successful UroLift System and features an enhanced delivery device tip designed to make it easier for urologists to treat BPH patients with a median lobe. The new UroLift 2 System is an evolution of the UroLift System platform and is engineered with innovative design features to enhance user confidence and ease of use including an ergonomic single trigger, an improved suture cutter, and simplified workflow.1 The eco-friendly Delivery Handle and implant cartridge design requires 66% less storage space, and generates nearly 50% less waste material per procedure, as compared to the prior generation UroLift System.1 Both new products support the continued utilization of the UroLift System in its full indication, which includes prostate volume


ę S&P Capital IQ 2021
All news about TELEFLEX INCORPORATED
10/14TELEFLEX INCORPORATED : Announces Third Quarter 2021 Earnings Conference Call Information
GL
10/08NORTH AMERICAN MORNING BRIEFING : Jobs Report in -3-
DJ
10/07TELEFLEX INCORPORATED : Downgraded by KeyBanc to Sector Weight From Overweight as Firm See..
MT
09/14TELEFLEX INCORPORATED : Announces Large-Scale Analysis of Real-World Healthcare Claims Dat..
AQ
09/14Teleflex Announces Large-Scale Analysis of Real-World Healthcare Claims Data for Enlarg..
CI
09/09TELEFLEX INCORPORATED : Unveils the UroLift Advanced Tissue Control (ATC)« System and the ..
AQ
09/09Teleflex Unveils the UroLift Advanced Tissue Control System and the UroLift 2 System
CI
09/07TELEFLEX INCORPORATED : Raymond James Reinstates Teleflex at Outperform with $440 Price Ta..
MT
09/01Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
GL
08/30TELEFLEX INCORPORATED : New Study Provides Insights into the Biocompatibility and Durabili..
AQ
More news
Analyst Recommendations on TELEFLEX INCORPORATED
More recommendations
Financials (USD)
Sales 2021 2 818 M - -
Net income 2021 416 M - -
Net Debt 2021 1 885 M - -
P/E ratio 2021 47,0x
Yield 2021 0,30%
Capitalization 17 639 M 17 639 M -
EV / Sales 2021 6,93x
EV / Sales 2022 6,37x
Nbr of Employees 14 000
Free-Float 97,3%
Chart TELEFLEX INCORPORATED
Duration : Period :
Teleflex Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TELEFLEX INCORPORATED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 376,90 $
Average target price 441,45 $
Spread / Average Target 17,1%
EPS Revisions
Managers and Directors
Liam J. Kelly Chairman, President & Chief Executive Officer
Thomas E. Powell Chief Financial Officer & Executive Vice President
Timothy F. Duffy Chief Information Officer & Vice President
Michelle Fox Chief Medical Officer & Vice President
Gwen Chapman Chief Compliance Officer & Vice President
Sector and Competitors
1st jan.Capi. (M$)
TELEFLEX INCORPORATED-8.42%17 639
ABBOTT LABORATORIES15.61%224 403
MEDTRONIC PLC5.48%166 288
BECTON, DICKINSON AND COMPANY-1.52%70 767
HOYA CORPORATION20.25%55 682
DEXCOM, INC.53.72%54 986